Skip to content
Screener

Elevance Health ELV Q1 2026 earnings

Reported April 22, 2026 · Before market open

Revenue$49.5BBeat by $1.3B
EPS$12.58Beat by $1.55
Revenue estimate$48.2B
EPS estimate$11.03

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$49.3B
EPS estimate$4.66

Financials

Q1 2026

Income statement

See full
Revenue$50.2B+2.6%
Gross profit$44.7B+1.8%
Net income$1.8B-19.2%
EPS (diluted)$8.00-16.8%

Balance sheet

See full
Cash & equivalents$9.7B+28.8%
Total debt$31.5B+11.0%
Total equity$43.9B+3.3%
Total assets$125.83B+5.1%

Cash flow

See full
Operating cash flow$4.3B+326%
CapEx$235.0M+19.9%
Free cash flow$4.1B+399%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$64.31B-34.7%
Enterprise value$86.14B-27.8%
P/E12.3×-4.4×
P/S0.3×-0.2×

Profitability

See full
Gross margin89.2%+0.6pp
Net margin2.6%-0.6pp
FCF margin3.3%+1.3pp

Returns & leverage

See full
Return on equity12.1%-2.1pp
Debt / equity0.7×+0.1×
Current ratio1.5×0.0×

Segments

By product

See full
Service fees$2.2B+8.5%

FAQ

When did Elevance Health report Q1 2026 earnings?
Elevance Health (ELV) reported Q1 2026 earnings on April 22, 2026 before market open.
What were Elevance Health's Q1 2026 revenue and EPS?
Elevance Health reported revenue of $49.5B and eps of $12.58 for Q1 2026.
Did Elevance Health beat estimates in Q1 2026?
Revenue beat the consensus estimate of $48.2B by $1.3B. EPS beat the consensus estimate of $11.03 by $1.55.
Where can I find Elevance Health's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001156039-26-000039) and the 10-Q periodic report (0001156039-26-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.